Related Experiment Video
Updated: Nov 16, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Insurance coverage and health care use among children with diabetes
Bina Amin1,2, Rishita Yeduri1,3, Dmitry Tumin1
1Department of Pediatrics, Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA.
Insights
Continuity of health insurance is vital for children with diabetes mellitus (DM). Gaps in coverage significantly reduce specialist visits, highlighting the need for consistent care access.
Area of Science:
- Pediatric Endocrinology
- Health Services Research
- Public Health
Background:
- Health insurance is linked to pediatric diabetes mellitus (DM) management.
- The impact of insurance continuity on healthcare utilization for pediatric DM is not well understood.
Purpose of the Study:
- To investigate the association between health insurance continuity and healthcare use outcomes in children with DM.
- To analyze how interruptions in insurance coverage affect emergency department visits, specialist visits, and unmet healthcare needs.
Main Methods:
- Utilized the 2016-2019 National Survey of Children's Health.
- Included children aged 0-17 years with DM.
- Classified insurance coverage as continuous private, continuous public, or discontinuous.
Main Results:
- 12% of children had discontinuous insurance coverage.
- Children with coverage gaps were significantly less likely to have seen a specialist (aOR: 0.27; P=0.030).
- 19% of children reported unmet healthcare needs.
Conclusions:
- Maintaining continuous health insurance is crucial for pediatric DM care.
- Efforts should focus on ensuring consistent specialist follow-up for children with DM, particularly those facing socioeconomic disadvantages.
Background:
Health insurance coverage may be associated with pediatric diabetes mellitus (DM) management. However, it is unknown how continuity of insurance coverage is associated with health care use outcomes in pediatric DM.
Methods:
We used the nationally representative 2016-2019 National Survey of Children's Health to examine how interruption of health insurance coverage may affect health care use among children with DM. Children ages 0-17 years with DM were included in the analysis. Outcomes included emergency department visits, specialist visits, and unmet health care needs in the last 12 months. Insurance coverage was classified as continuous private, continuous public, or discontinuous (including gaps in coverage and year-round lack of coverage).
Results:
Based on a sample of 548 children, 56% percent had continuous private insurance coverage, as compared to 32% with continuous public insurance, and 12% with discontinuous coverage. Thirty-five percent of children had visited the ED in the past 12 months, and only 47% had visited any specialist in the past 12 months, including but not limited to a pediatric endocrinologist. An estimated 19% of children had unmet health care needs over the past 12 months. On multivariable analysis, children with coverage gaps were significantly less likely than children with continuous private coverage to have a visited a specialist in the past 12 months (adjusted odds ratio: 0.27; 95% CI: 0.08, 0.88; p = 0.030).
Conclusions:
This study points to a need to establish and maintain specialist follow-up for children with DM, especially those from socioeconomically disadvantaged backgrounds.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications

